During the quarter, we initiated new positions in nLIGHT, Guardant Health and Cellebrite. We also added to Bruker, Hexcel and Penumbra during the quarter. Along with Insmed, we also ended our investment campaigns in Integer Holdings and SharkNinja during the quarter.
Flex remains attractively valued versus peers, despite a 179% return since January 2024 and a strong operational shift. FLEX's transition to higher-margin products like AI data centers and automotive systems has driven improved profitability and resilient cash flow. FY2026 guidance projects revenue of $26.7–$27.3 billion, with gross margin rising to 9.14% and levered free cash flow at $998.4 mi...
AUSTIN, Texas, Jan. 14, 2026 /PRNewswire/ -- Flex (NASDAQ: FLEX) will announce its third quarter fiscal year 2026 financial results before the market opens on Wednesday, Feb. 4, 2026. The company will hold a conference call to discuss the results that day at 7:30 AM CT / 8:30 AM ET.
aktien.guide ist das Tool zum einfachen Finden, Analysieren und Beobachten von Aktien. Lerne von erfolgreichen Investoren und triff fundierte Anlageentscheidungen. Wir machen Dich zum selbstbestimmten Investor.